CN101759767A - Method for synthesizing glycylglycine - Google Patents

Method for synthesizing glycylglycine Download PDF

Info

Publication number
CN101759767A
CN101759767A CN200810121715A CN200810121715A CN101759767A CN 101759767 A CN101759767 A CN 101759767A CN 200810121715 A CN200810121715 A CN 200810121715A CN 200810121715 A CN200810121715 A CN 200810121715A CN 101759767 A CN101759767 A CN 101759767A
Authority
CN
China
Prior art keywords
glycylglycine
ethanol
people
add
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810121715A
Other languages
Chinese (zh)
Inventor
严海燕
吴菁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUZHOU LAISE BIOLOGICAL GENE ENGINEERING Co Ltd
Original Assignee
HUZHOU LAISE BIOLOGICAL GENE ENGINEERING Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUZHOU LAISE BIOLOGICAL GENE ENGINEERING Co Ltd filed Critical HUZHOU LAISE BIOLOGICAL GENE ENGINEERING Co Ltd
Priority to CN200810121715A priority Critical patent/CN101759767A/en
Publication of CN101759767A publication Critical patent/CN101759767A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a method for synthesizing glycylglycine, which comprises the following steps of: taking glycine as a raw material, adding glycerol to perform reflux reaction with stirring at the temperature of between 175 and 180 DEG C, and adding distilled water after cooling and putting the mixture into a refrigerator to stay overnight; performing filtration and washing the mixture with ethanol to prepare an intermediate product, namely 2,5-diketopiperazine; hydrolyzing the 2,5-diketopiperazine in the presence of NaOH, adding hydrochloric acid and regulating the pH to 6.0, and then adding the ethanol to stay overnight in the refrigerator; and finally performing filtration and washing the mixture with the ethanol until no chloridion exists to prepare the glycylglycine, wherein the yield of the glycylglycine is 81 percent. The method has the advantages of simpleness, difficult cause of environmental pollution, and suitability for industrialized production.

Description

A kind of synthetic method of glycylglycine
Technical field
The invention relates to a kind of synthetic method of glycylglycine, belong to chemical pharmacy field.
Background technology
Glycylglycine (L-Glycylglycine) has another name called N-glycylglycine, contract diamino-acetic acid, glycylglycine or sweet victory, structural formula:
Figure G2008101217157D0000011
Molecular formula: C 4H 8N 2O 3, CAS number: 556-50-3.Glycylglycine is white lobate crystallization, and fusing point is 260~262 ℃ (decomposition).In the time of 25 ℃ in the water solubleness be 13.4g/100mL, be soluble in hot water, be insoluble in alcohol, be insoluble to ether.
Glycylglycine is a kind of biochemical reagents, in biological study and pharmaceutically as the stablizer of blood preservation and pharmaceutical grade protein cytochrome C aqueous injection, can be used to measure the substrate of glycylglycine pepx, and synthetic polypeptide.And glycylglycine is as a kind of small peptide, and the interaction of itself and transition metal has critical effect in fields such as many biotechnology and pharmaceutical chemistry.
Also few for the synthetic method of glycylglycine at present.Because amino acid and polypeptide is synthetic comparatively complicated; require active a-amino acid; couple together in certain sequence; keep opticity constant again; and have peptide bond to exist in the polypeptide; various reactions easily taking place, separate etc. as hydrolysis, ammonia, therefore needs to introduce protecting group and protect amino acid whose carbon teminal or nitrogen end.
Summary of the invention
One of purpose of the present invention provides a kind of synthetic method of glycylglycine.
Technical solution of the present invention is as follows:
1, intermediate 2, the preparation of 5-piperazinedione.
30mL glycerine is added in the flask that people 100mL is equipped with reflux exchanger, under agitation add the glycine 12g of porphyrize, stir 50min in 175~180 ℃.Be cooled to room temperature, add people 12mL distilled water, put people's refrigerator overnight.Suction filtration is used 50% washing with alcohol, gets crude product 2, the 5-piperazinedione.The water recrystallization promptly gets pure product.M.p.300~302 ℃, productive rate 89%.
2, generate glycylglycine.
In the 250mL round-bottomed flask, add the sodium hydroxide solution of people 50mL 1mol/L, under agitation add people 5g2, the 5-piperazinedione, stirring at room to 2, the 5-piperazinedione all dissolves, add 2mol/L hydrochloric acid 25mL then, regulating pH is 6.0, is evaporated to about 20mL, add people 30mL 95% ethanol, in refrigerator, place and spend the night suction filtration, washing with alcohol with 70%, in washings till the no chlorion, glycylglycine .m.p.258~260 ℃, productive rate 81%.
The method applied in the present invention is simple and easy to do, and productive rate is higher.By utilizing glycerine is a kind of high boiling point (boiling point is 290 ℃) solvent, can form very strong hydrogen bond with water molecules, so have the intensive water-absorbent.Utilize this character, glycine is easy to dehydration condensation in 175~180 ℃ in glycerine, generate corresponding intermediate product 2, the 5-piperazinedione, and then effectively protected the nitrogen end of glycine.Material reagent required for the present invention is inexpensive and be easy to get, and operational path is short, the yield height, and be difficult for contaminate environment, be suitable for suitability for industrialized production.

Claims (8)

1. the synthetic method of a glycylglycine is characterized in that may further comprise the steps:
(1) glycerine is added the people and be equipped with in the flask of reflux exchanger, under agitation add the glycine of porphyrize.Be cooled to room temperature, add an amount of distilled water of people, put people's refrigerator overnight.Suction filtration is used washing with alcohol, gets crude product 2, the 5-piperazinedione.The water recrystallization promptly gets pure product.
(2) in the 250mL round-bottomed flask, add people's sodium hydroxide solution, under agitation add people 2, the 5-piperazinedione is stirred to 2, and the 5-piperazinedione all dissolves, add hydrochloric acid then, regulate pH, behind the concentrating under reduced pressure, add people's ethanol, place in refrigerator and spend the night, suction filtration is used washing with alcohol, in washings, till the no chlorion, get glycylglycine.
2. according to the said stirring and refluxing reaction of claim 1 (1), it is characterized in that the glycerine volume: glycine quality=5mL: 2g, the temperature of reaction is 175~180 ℃, the stirring reaction time is 50min.
3. according to the said washing composition of claim 1 (1), it is characterized in that used solution is 50% ethanol
4. according to the said hydrolysis reaction of claim 1 (2), it is characterized in that concentration of sodium hydroxide solution is 1mol/L, and the sodium hydroxide solution volume: 2,5-piperazinedione quality=10mL: 1g, temperature of reaction is a room temperature.
5. according to the said hydrochloric acid soln of claim 1 (2), it is characterized in that concentration is 2mol/L, and the sodium hydroxide solution volume: hydrochloric acid soln volume=2: 1
6. according to the said pH regulator of claim 1 (2), it is characterized in that pH regulator to 6.0.
7. according to the reaction of the said concentrating under reduced pressure of claim 1 (2), it is characterized in that volume ratio is 15: 4 before and after the decompression, and with 95% ethanol removal of impurities, and the liquor capacity behind the concentrating under reduced pressure: volumes of aqueous ethanol=2: 3.
8. according to the said washing composition of claim 1 (2), it is characterized in that used solution is 70% ethanol.
CN200810121715A 2008-10-23 2008-10-23 Method for synthesizing glycylglycine Pending CN101759767A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810121715A CN101759767A (en) 2008-10-23 2008-10-23 Method for synthesizing glycylglycine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810121715A CN101759767A (en) 2008-10-23 2008-10-23 Method for synthesizing glycylglycine

Publications (1)

Publication Number Publication Date
CN101759767A true CN101759767A (en) 2010-06-30

Family

ID=42491163

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810121715A Pending CN101759767A (en) 2008-10-23 2008-10-23 Method for synthesizing glycylglycine

Country Status (1)

Country Link
CN (1) CN101759767A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103204905A (en) * 2013-03-15 2013-07-17 四川同晟生物科技有限公司 Method for synthesizing tetra-glycylglycine
CN105254576A (en) * 2014-02-26 2016-01-20 中国科学院长春应用化学研究所 Method for preparing glutamic piperazinedione
WO2019028340A1 (en) 2017-08-03 2019-02-07 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
WO2019200251A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
WO2021174039A1 (en) 2020-02-28 2021-09-02 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103204905A (en) * 2013-03-15 2013-07-17 四川同晟生物科技有限公司 Method for synthesizing tetra-glycylglycine
CN105254576A (en) * 2014-02-26 2016-01-20 中国科学院长春应用化学研究所 Method for preparing glutamic piperazinedione
WO2019028340A1 (en) 2017-08-03 2019-02-07 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
WO2019200251A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
WO2021174039A1 (en) 2020-02-28 2021-09-02 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations

Similar Documents

Publication Publication Date Title
CN101759767A (en) Method for synthesizing glycylglycine
TW458961B (en) Amino acid-derived diaminopropanols
CN1834092B (en) Preparation of pramipexole
CN101372473B (en) Preparation of N-hydroxy diimide
CN112225761A (en) Pyrimidotriazole and synthetic method thereof
CN102268029B (en) Preparation method of compound (1S, 2S, 3R, 5S)-pinanediol-L-phenylalanine-L-leucine boric acid ester
CN101869814A (en) Long chain cation gemini surfactant and preparation method thereof
CN101186587B (en) Method for synthesizing derivative of beta-amino acid and intermediate product thereof
US9346772B2 (en) Preparation method for an imine compound and reduction method for solid powder of a carbamic acid derivative
CN1762989A (en) Semicarbazone synthesis method
CN103601675A (en) Novel preparation method of 5-aminomethyl nicotinic acid
CN112094237A (en) Synthesis method of fluorobenzene imidazole
CN104760939B (en) A kind of synthesis technique of the sodium azide aqueous phase of n-butanol recycled
CN105272969A (en) Preparation method of candesartan cilexetil
CN112028799B (en) Preparation method of 1, 4-dithiothreitol
CN115073252B (en) 13C Mexaxetine and synthesis method of 13C phenacetin
US20140051858A1 (en) Preparing method of solid carbamic acid derivatives
CN109824553A (en) 2-((tert-butoxycarbonyl) amino) ethyl-1- sulfonic acid and preparation method thereof
CN114105796B (en) Synthesis method of stable isotope deuterium labeled isoleucine
CN101830842B (en) Preparation method of functional amino proline
CN106475143A (en) (R) the unilateral Fe Anderson type heteropolyacid catalyst modified of 1 (2 hydroxyl 1 phenethyl) thiourea, preparation method and applications
Pappas et al. Phenyl esters, preferred reagents for mono-acylation of polyamines in the presence of water
US20060063950A1 (en) Synthesis process for 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid
CN115873012A (en) Biotin-perfluorocarboxylic acid compound and preparation method thereof
CN116903522A (en) Synthesis method of 1-carbobenzoxy-6-trifluoromethyl piperidine-3-methyl formate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Huzhou Laise Biological Gene Engineering Co., Ltd.

Document name: Notification that Application Deemed to be Withdrawn

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100630